Table 2.
Study Inclusion/exclusion criteria
| Inclusion criteria | Exclusion criteria | |
|---|---|---|
| Country setting | Present data from a country in the EU or EU in general | Only present data from a non-EU country. No data specific to the EU. |
| Population | Adults with HZ or PHN | Children |
| Focus mainly on chicken pox | ||
| Immunodepressed patients only (e.g. HIV patients) | ||
| Studies that contain information on key search terms (inc. QoL, burden, productivity) | Studies that do NOT contain information on key search terms | |
| Study design | Real world data, observational studies, effectiveness, qualitative research and cost studies | Clinical trials of efficacy and safety of treatments presenting QoL data as secondary endpoint only |
| Clinical trials of Zostavax | ||
| Focus mainly on epidemiological evidence (e.g. incidence, prevalence etc.) | ||
| Publication type | For conference abstracts, exclusion if manuscript corresponding to this abstract and presenting equivalent information is already published | |